Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc.

Overview
Headquarters

50 Northern Avenue,Suite 2303,Boston, MA 02210

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Other Business & Consulting Services
Medical Support Services
Hospitals & Patient Services
Biotechnology
Holding Companies

Company Description

Entrada Therapeutics, Inc. operates as a biotechnology company. It focuses on delivery of biomolecules into the cell to treat devastating diseases. The firm offers intracellular enzyme replacement therapy and protein-protein interaction inhibitors programs. The company was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.

Executives & Employees

President & Chief Executive Officer

Chief Financial Officer

Chief Operating Officer

Chief Medical Officer

Board of Directors

Managing Partner at 5AM Venture Management LLC

Venture Partner at 5AM Venture Management LLC

President & Chief Executive Officer at Entrada Therapeutics, Inc.

Chief of Staff at Bill & Melinda Gates Medical Research Institute

Chairman of the Board, Chief Executive Officer at Amicus Therapeutics, Inc.

Chief Executive Officer at Roche Ventures

Venture Partner at 5AM Venture Management LLC

Managing Director at MPM Asset Management LLC

Partner at BB Pureos Bioventures

Partner at Merck Research Ventures

Paths to Entrada Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Entrada Therapeutics, Inc.
Recent Transactions
Details Hidden

Entrada Therapeutics, Inc. raised money in a private placement transaction

Investors
Details Hidden

MPM invests in companies located in the US and across the globe. The firm focuses on companies that aim to revolutionize the face of medicine across multiple areas including cancer, diabetes, obesity, pain, eHealth and health technology sector. They provide financing for early stage transactions.

Details Hidden

5AM Ventures invests in next-generation life sciences companies located in the US. The firm targets companies operating in the fields of biopharmaceutical, drug delivery technologies and research instruments. They provides financing for early stage and corporate spin-out capital requirements with an investment size ranging from $20 to $30 million and also makes co-investments.

Details Hidden

Redmile Group LLC /Private Equity/ is a private equity firm located in the US. The firm targets companies operating in the fields of technology. It provides financing for buyout transactions.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Entrada Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Entrada Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Entrada Therapeutics, Inc..